Baillie Gifford & CO Schrodinger, Inc. Transaction History
Baillie Gifford & CO
- $128 Billion
- Q2 2025
A detailed history of Baillie Gifford & CO transactions in Schrodinger, Inc. stock. As of the latest transaction made, Baillie Gifford & CO holds 985,660 shares of SDGR stock, worth $18.6 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
985,660
Previous 994,819
0.92%
Holding current value
$18.6 Million
Previous $19.6 Million
0.99%
% of portfolio
0.02%
Previous 0.02%
Shares
16 transactions
Others Institutions Holding SDGR
# of Institutions
264Shares Held
71.3MCall Options Held
1.66MPut Options Held
246K-
Black Rock Inc. New York, NY8.52MShares$161 Million0.0% of portfolio
-
Bill Gates Bill & Melinda Gates Foundation Trust | Kirkland, Wa6.98MShares$132 Million0.29% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.62MShares$125 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY5MShares$94.3 Million2.32% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.3.65MShares$68.8 Million0.05% of portfolio
About Schrodinger, Inc.
- Ticker SDGR
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 62,028,400
- Market Cap $1.17B
- Description
- Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences i...